Factors Associated With Paradoxical Masseteric Bulging After Botulinum Toxin Injection for Masseter Hypertrophy: A Retrospective Analysis
Journal of Cosmetic Dermatology · 2026-04 · 25 (4)
DOI: 10.1111/jocd.70830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 25.04.2026. Verfasst von Yi-Dan Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Peking University Shenzhen Hospital, Shenzhen, P. R. China. Hauptthemen laut MEDLINE: Botulinum Toxins, Masseter Muscle, Injections, Intramuscular, Neurotoxins. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation from Shenzhen Science and Technology Innovation Commission, Shenzhen Key Medical Discipline Construction Fund.
Abstract (Originalsprache)
Background
Botulinum neurotoxin (BoNT) injection is the preferred minimally invasive treatment for masseter hypertrophy, but paradoxical masseteric bulging (PMB) is a distressing complication. How to clinically prevent and avoid the development of PMB remains a key concern for injecting physicians.
Methods
This study collected ultrasound and injection data from 22 PMB masseter muscles and 66 non‐PMB masseter muscles between September 2024 and January 2025. Univariate analysis was used to compare imaging and injection‐related parameters between the two groups, including masseter prominence, masseter thickness, deep inferior tendon (DIT) type, DIT thickness, intraoperative tactile sensation, and injected agent.
Results
Univariate analysis showed significant intergroup differences in masseter prominence grade, DIT type, DIT thickness, masseter thickness, injection dosage, and intraoperative tactile sensation (all p < 0.05). The PMB group had greater masseter thickness (13.30 ± 0.171 mm vs. 10.32 ± 0.169 mm), thicker DIT (0.85 [0.348] mm vs. 0.60 [0.208] mm), and a higher incidence of fascial penetration sensation than the control group.
Conclusion
Preoperative ultrasound assessment of masseter and DIT characteristics, combined with individualized layered injection and intraoperative tactile feedback, effectively mitigates PMB risk. Ultrasound‐guided precise supplementary injection is the preferred intervention for PMB management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, Peking University Shenzhen Hospital, Shenzhen, P. R. China.
- Department of Plastic Surgery, Shenzhen Xinhua Hospital, Shenzhen, P. R. China.
ORCID-Profile: Dan-Dan Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation from Shenzhen Science and Technology Innovation Commission
- Shenzhen Key Medical Discipline Construction Fund
- Peking University Shenzhen Hospital Research Fund
- Guangdong Medical Science and Technology Research Foundation
Zitieren
APA
Sun, Y. D., Xu, X. W., Luo, L., Ou, Y. T., Cui, Y. Y., & Liu, D. D. (2026). Factors Associated With Paradoxical Masseteric Bulging After Botulinum Toxin Injection for Masseter Hypertrophy: A Retrospective Analysis. Journal of Cosmetic Dermatology, 25(4). https://doi.org/10.1111/jocd.70830
Vancouver
Sun YD, Xu XW, Luo L, Ou YT, Cui YY, Liu DD. Factors Associated With Paradoxical Masseteric Bulging After Botulinum Toxin Injection for Masseter Hypertrophy: A Retrospective Analysis. Journal of Cosmetic Dermatology. 2026;25(4). doi:10.1111/jocd.70830
BibTeX
@article{Sun2026,
author = {Sun, Yi-Dan and Xu, Xiang-Wen and Luo, Lin and Ou, Yan-Ting and Cui, Yong-Yan and Liu, Dan-Dan},
title = {Factors Associated With Paradoxical Masseteric Bulging After Botulinum Toxin Injection for Masseter Hypertrophy: A Retrospective Analysis},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {4},
doi = {10.1111/jocd.70830}
}
EUVIMED